**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no
implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information
is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
American Association for Cancer Research
a/k/a: AACR
Address:
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
USA
Phone: 215-440-9300
Fax: 215-440-9313
800 Number: 866-423-3965
TDD: --
Email Address: aacr@aacr.org
The American Association for Cancer Research (AACR), a scientific society of over 13,000 laboratory and clinical cancer researchers, was founded in 1907 to facilitate communication and dissemination of knowledge among scientists and others dedicated to cancer issues; foster research in cancer and related biomedical sciences; encourage presentation and discussion of new and important observations in the field; foster public education, science education, and training; and advance the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world. The AACR publishes four journals; convenes an annual meeting attended by more than 7,500 scientists from around the world; organizes several scientific conferences each year on new and significant developments in research; offers educational workshops and grants to young investigators; maintains an active public education program; and interacts frequently with cancer survivors, lay advocates, and the general public in support of its mission.
Website: http://www.aacr.org/
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted
by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to
the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes
without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on
an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source
(NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed
versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.